PRECISIONvalue is a 2022 Manny Awards Finalist!
Each year, Med Ad News honors the best in healthcare communications and advertising through the Manny Awards. This year, we are excited to announce that PRECISIONvalue has been selected as a 2022 Manny Awards finalist in the Best Managed Markets Campaign Category for “Overcoming Hurdles”.
PRECISIONxtract adds two senior executives
PRECISIONxtract announces the addition of two senior executives as it launches its digital data tool OncoGenius. Bruce Edelen will step into the role of SVP, OncoGenius franchise lead and Ron Schleif will serve as SVP, oncology provider group management and survey operations.
The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation
Over the last decade, healthcare costs have continued to rise in the United States while outcomes have been stagnant and, in some cases, declined. Implementation of strategies around patient- or consumer-driven care has been a struggle as stakeholders try to define, measure, and improve the patient experience.
Cancer Screening in Limbo: What are the Implications?
Pre-pandemic cancer death rates were trending downward at an encouraging rate. However, global instability from COVID-19 has resulted in disruption to vital cancer screenings and treatment.
On-Demand Webinar: Planning for the Commercialization of Advanced Therapies
In January, the Alliance for Regenerative Medicine (ARM) released its State of the Industry Briefing which highlighted a record-breaking year for 2021. $23.1B raised for the advanced medicines sector (a 16% increase from 2020), 2,261 ongoing regenerative medicine clinical trials globally, and the evolution from treating and curing rare monogenetic diseases to more prevalent indications. Could we see 10-20 approvals each year by 2025?
Removal of the Medicaid Rebate Cap: Sensible or Nonsense?
The American Rescue Plan of 2021 introduced a provision to remove the Medicaid Rebate Cap of 100%, effective January 2024. This legislation may turn profits upside down for a pharmaceutical company with a significant presence. Precision’s Cynthia Miller discusses what it would mean to remove the Medicaid Rebate Cap, how it would affect pharmaceutical companies, and strategies for moving forward.
PRECISIONxtract Launches OncoGenius, Empowering Oncology Brands With New Insights From Provider-level Data
Recent acquisition of veteran pharmaceutical market consultancy Oncology Reimbursement Management propels and further elevates Precision’s oncology commercialization solutions.
‘Alexa, I want to talk to a doctor’: Amazon, Teladoc partner on virtual care
In the most recent Big Tech foray into digital healthcare, Amazon and Teladoc Health announced they will be partnering on a program to provide virtual medical care. Users of Amazon’s Alexa-enabled devices will now be able to contact a doctor via voice command about non-emergency conditions on a 24/7 basis. Precision’s Cynthia Miller weighs in on the benefits and shortfalls, including access problems in marginalized communities and rural areas.
Market Access and Commercialization with Greg Gregory
Congratulations to PRECISIONadvisors Executive Vice President and Managing Director Greg Gregory on his well-attended seminar “Market Access and Commercialization” as part of Brown University’s digital health commercialization seminar series.
Miss the session and want to learn more market access considerations for digital health innovations?
On-demand Webinar- 2022 and Beyond: How Key Legislative Events will impact the payer landscape
A number of legislative events are shaping the managed care landscape in 2022. These events range from broad reaching initiatives outlined in Biden’s Build Back Better Framework to proposals for promoting adoption of biosimilars to Medicare’s Advance Notice for the 2023 benefit year and discussions around Part D re-design as well as others.
